Approval · Notice of Compliance 1036 · 2000
CAPTOPRIL: Notice of Compliance 1036
Issued September 6, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1036
- Date
- September 6, 2000
- Company
- Zymcan Pharmaceuticals Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
- Canadian reference product
- CAPOTEN